Nigeria Set to Receive Crucial Leprosy Treatments After Year-Long Shortage

Sun Sep 06 2026 07:53:00 GMT+0000 (Coordinated Universal Time)

The World Health Organization announces the arrival of leprosy drugs to Nigeria, addressing a year-long supply crisis affecting thousands of patients.

More than 2,000 new leprosy cases are reported annually in Nigeria, where patients have faced a year without access to vital drugs. The WHO's intervention is expected to restore treatment availability, as experts stress the urgent need to control the disease's transmission and prevent further health deterioration among patients.

Nigeria is on the verge of receiving essential leprosy drugs for the first time in a year, a development announced by the World Health Organization (WHO). The country, which reports over 2,000 new leprosy cases annually, has struggled with drug shortages due to shipping delays associated with newly introduced regulations. WHO representatives have urged Nigeria to temporarily relax its new testing policy to facilitate the faster arrival of these crucial medications, which are expected to reach the country from India soon.

Leprosy, a curable disease that responds well to a combination of antibiotics, can still lead to serious complications, such as sores and nerve damage, if untreated. The treatment course typically lasts from six to twelve months; however, due to the ongoing drug shortage, many patients have been discharged from hospitals without adequate care, significantly raising the risk of disease transmission within communities.

Dr. Samimu Msheliza, a public health expert and medical advisor for the Leprosy Mission in Nigeria, emphasized the critical need for immediate access to medication. "Thousands of newly diagnosed leprosy patients across various cities are just waiting for this drug," he explained. He urged for urgent action as untreated cases continue to spread the virus, worsening the public health crisis.

A testimony from Awwal Musa, a patient at a hospital in Nasarawa State, reveals the dire consequences of the drug shortage. Musa's condition has deteriorated significantly during the last year of missed treatments, exacerbating her symptoms and causing severe pain. "Before last year, my wounds were healing, but now they are worse. The pain has increased," she shared, pointing to the risk of irreversible nerve damage.

The new regulations enforced by Nigeria's drug authority were intended to combat counterfeit medications and ensure the safety of pharmaceutical imports. However, these measures have inadvertently hindered the availability of vital treatments, including those for leprosy.

As efforts continue to address this public health issue, local and international activities remain focused on ensuring patients receive the care they need.